login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CYBIN INC (CYBN) Stock News
USA
-
NYSE Arca
- NYSEARCA:CYBN -
CA23256X4075
-
Common Stock
5.95
USD
+0.32 (+5.68%)
Last: 12/4/2025, 5:15:37 PM
6
USD
+0.05 (+0.84%)
After Hours:
12/4/2025, 5:15:37 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CYBN Latest News, Press Relases and Analysis
All
Press Releases
21 days ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
22 days ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin to Participate in the Jefferies Global Healthcare Conference in London
a month ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
21 days ago - By: Benzinga
- Mentions:
ECC
VINP
INV
VTGN
...
Earnings Scheduled For November 13, 2025
22 days ago - By: Benzinga
What's Next: Cybin's Earnings Preview
a month ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
a month ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
a month ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin Announces Closing of $175 Million Registered Direct Offering
a month ago - By: Cybin Inc.
- Mentions:
CBOE
Cybin Announces $175 Million Registered Direct Offering
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
2 months ago - By: Cybin Inc.
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: The Schall Law Firm
CYBN Investors Have Opportunity to Join Cybin Inc. Fraud Investigation with the Schall Law Firm
3 months ago - By: Cybin Inc.
Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
3 months ago - By: Cybin Inc.
Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder
3 months ago - By: Cybin Inc.
Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Yahoo Finance
- Mentions:
DB
PEP
UTHR
STZ
...
Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint
3 months ago - By: Cybin Inc.
Cybin to Participate in the Cantor Global Healthcare Conference 2025
3 months ago - By: Cybin Inc.
Cybin Announces Senior Leadership Changes
3 months ago - By: Cybin Inc.
Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
4 months ago - By: Cybin Inc.
Cybin Announces Results of Annual Meeting of Shareholders
4 months ago - By: Cybin Inc.
Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results
4 months ago - By: Cybin Inc.
Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
4 months ago - By: Cybin Inc.
Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference
5 months ago - By: Cybin Inc.
Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
5 months ago - By: Cybin Inc.
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Please enable JavaScript to continue using this application.